Jupiter Life Line Hospitals Limited - Asset Resilience Ratio

Latest as of September 2025: 26.57%

Jupiter Life Line Hospitals Limited (JLHL) has an Asset Resilience Ratio of 26.57% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs5.37 Billion
≈ $58.13 Million USD Cash + Short-term Investments

Total Assets

Rs20.23 Billion
≈ $218.76 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Jupiter Life Line Hospitals Limited's Asset Resilience Ratio has changed over time. See JLHL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Jupiter Life Line Hospitals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Jupiter Life Line Hospitals Limited worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs5.37 Billion 26.57%
Total Liquid Assets Rs5.37 Billion 26.57%

Asset Resilience Insights

  • Very High Liquidity: Jupiter Life Line Hospitals Limited maintains exceptional liquid asset reserves at 26.57% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Jupiter Life Line Hospitals Limited Industry Peers by Asset Resilience Ratio

Compare Jupiter Life Line Hospitals Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Fresenius SE & Co. KGaA
XETRA:FRE
Medical Care Facilities 9.40%
Encompass Health Corp
NYSE:EHC
Medical Care Facilities 0.51%
Extendicare Inc
TO:EXE
Medical Care Facilities 32.62%
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Medical Care Facilities 9.01%
Hospital Mater Dei S.A
SA:MATD3
Medical Care Facilities 0.63%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%

Annual Asset Resilience Ratio for Jupiter Life Line Hospitals Limited (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Jupiter Life Line Hospitals Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 12.32% Rs2.35 Billion
≈ $25.37 Million
Rs19.05 Billion
≈ $206.01 Million
-10.71pp
2024-03-31 23.03% Rs2.95 Billion
≈ $31.91 Million
Rs12.81 Billion
≈ $138.57 Million
+22.89pp
2023-03-31 0.14% Rs14.00 Million
≈ $151.40K
Rs9.86 Billion
≈ $106.58 Million
-0.16pp
2022-03-31 0.30% Rs27.31 Million
≈ $295.35K
Rs9.09 Billion
≈ $98.27 Million
-0.61pp
2021-03-31 0.91% Rs72.08 Million
≈ $779.52K
Rs7.89 Billion
≈ $85.32 Million
+0.55pp
2020-03-31 0.36% Rs21.85 Million
≈ $236.30K
Rs6.03 Billion
≈ $65.20 Million
--
pp = percentage points

About Jupiter Life Line Hospitals Limited

NSE:JLHL India Medical Care Facilities
Market Cap
$226.19 Million
Rs20.92 Billion INR
Market Cap Rank
#16057 Global
#830 in India
Share Price
Rs319.00
Change (1 day)
-3.77%
52-Week Range
Rs314.90 - Rs1595.20
All Time High
Rs1698.55
About

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT,… Read more